Abstract
IntroductionA December 2019 WHO rapid communication recommended the use of 9-month all-oral regimens for treating multidrug-resistant tuberculosis (MDR-TB). Besides the clinical benefits, they are thought to be less costly than...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have